Massimo Zecchin

Dr. Massimo Zecchin


Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2013 in Marine and Petroleum Geology
Verified
Journal Article
Closed access
Massimo ZecchinMassimo Zecchin
Massimo Zecchin
OCOctavian Catuneanu
Octavian Catuneanu

14 December 2013 in European Journal of Heart Failure
Verified
Journal Article
Open access
PDF file
MMMarco Merlo
Marco Merlo
APAlberto Pivetta
Alberto Pivetta
BPBruno Pinamonti
Bruno Pinamonti
DSDavide Stolfo
Davide Stolfo
MZMassimo Zecchin
Massimo Zecchin
GSGianfranco Sinagra
Gianfranco Sinagra
Aims ACE-inhibitors, β-blockers, implantable cardioverter–defibrillator (ICD) and cardiac resynchronization therapy (CRT) improved prognosis of heart failure. We sought to analyse the long-term prognostic impact of evidence-based integrated therapeutic strategies in patients with idiopathic dilated cardiomyopathy (IDCM). Methods and results From 1978 to 2007, 853 IDCM patients (45 ± 15 years, 72% males) were enrolled and classified as follows: Group 1, 110 patients (12.8%) enrolled during 1978–1987; Group 2, 376 patients (44.1%) enrolled during 1988–1997; Group 3, 367 patients (43.1%) enrolled during 1998–2007. ACE-inhibitors/angiotensin receptor blockers were administered in 34%, 93%, and 93% (P <0.001), and β-blockers in 11%, 82%, and 86% (P <0.001) in Groups 1, 2, and 3, respectively; ICDs were implanted in 2%, 14%, and 13% (P = 0.005); mean time to device implantation was lower in Group 3. At 8 years, heart transplant (HTx)-free survival rates were 55%, 71%, and 87% in Groups 1, 2, and 3, respectively (P <0.001). Similar progressive improvement was found for pump-failure death (DHF)/HTx, while survival free from sudden death (SD) was significantly improved only in Group 3. Multivariable models considering competing risk indicated early diagnosis (i.e. a baseline less advanced disease stage) and tailored medical therapy (HR 0.44, CI 95% 0.19–0.98) as independent protectors against DHF/HTx. Concerning SD, lower left ventricular ejection fraction emerged as a predictor, while ICD was the only therapy with a protective role (HR 0.08, CI 95% 0.01–0.61). Treatment with digitalis emerged as a predictor of both DHF/HTx and SD. Conclusions An effective management and evidence-based integrated therapeutic approach progressively and significantly improved the long-term prognosis of IDCM during the last three decades.

1 March 1997 in JACC
Verified
Journal Article
Closed access
BPBruno Pinamonti
Bruno Pinamonti
MZMassimo Zecchin
Massimo Zecchin
ALAndrea Di Lenarda
Andrea Di Lenarda
Dario GregoriDario Gregori
Dario Gregori
GSGianfranco Sinagra
Gianfranco Sinagra
FCFulvio Camerini
Fulvio Camerini

1 January 2013 in Marine and Petroleum Geology
Verified
Journal Article
Closed access
OCOctavian Catuneanu
Octavian Catuneanu
Massimo ZecchinMassimo Zecchin
Massimo Zecchin

1 January 2019 in Earth-Science Reviews
Verified
Journal Article
Closed access
Massimo ZecchinMassimo Zecchin
Massimo Zecchin
OCOctavian Catuneanu
Octavian Catuneanu
MCMauro Caffau
Mauro Caffau